MedTrace Logo

26 Weeks' Dietary Supplementation With DHA- and EPA-enriched Oils on Cerebral Blood Flow in Healthy Adults

NCT03158545 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 78

Last updated 2017-09-12

No results posted yet for this study

Summary

The purpose of this study is to investigate the effects of EPA- and DHA-enriched omega-3 polyunsaturated fatty acid dietary supplements on cerebral blood flow during a series of cognitive, mathematical subtraction tasks and subjective ratings of task difficulty before and after 26 weeks of supplementation

Conditions

  • Neurovascular Coupling

Interventions

DIETARY_SUPPLEMENT

Olive oil Placebo

olive oil

DIETARY_SUPPLEMENT

EPA-rich

EPA-rich omega-3 oil

DIETARY_SUPPLEMENT

DHA-rich

DHA-rich omega-3 oil

Sponsors & Collaborators

  • Pronova BioPharma

    collaborator INDUSTRY

  • Northumbria University

    lead OTHER

Principal Investigators

  • Philippa Jackson, PhD · Northumbria University

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
25 Years
Max Age
49 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-10-10
Primary Completion
2017-09-04
Completion
2017-09-04

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03158545 on ClinicalTrials.gov